Fibrotic Interstitial Lung Disease (ILD) is a debilitating condition that affects the lung tissue, leading to scarring and impaired lung function. It can cause symptoms such as shortness of breath, persistent cough, and fatigue, significantly impacting one’s quality of life.
A Bilateral Lung Transplant (BLT) is a surgical procedure that involves replacing both diseased lungs with healthy donor lungs. For individuals with advanced fibrotic ILD, a BLT can be a life-saving treatment option. By replacing the damaged lungs, a BLT can restore lung function and enhance the overall quality of life. This procedure is typically reserved for patients who have exhausted other treatments and have a significant decline in lung function.
BLT is a complex procedure that requires a highly skilled surgical team and comprehensive post-operative care. After the surgery, patients require lifelong immunosuppressive medications to prevent rejection of the transplanted organ. Regular follow-up visits and close monitoring are necessary to ensure the success of the transplant and the well-being of the recipient. With the advances in surgical techniques and post-transplant care, the success rates of Bilateral Lung Transplants have significantly improved over the years.
Mr. Sudev V from Alappuzha, Kerala, successfully underwent Bilateral Lung Transplant for Fibrotic Interstitial Lung Disease at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Balasubramoniam K R, Consultant Robotic and Minimally Invasive Thoracic Surgeon, Dr. Manjunath Bale, Consultant Robotic and Minimally Invasive Thoracic Surgeon, Dr. Chetan Rao Vaddepally, Consultant Interventional and Transplant Pulmonologist, Dr. Sricharan Goda, Consultant Critical Care Medicine, Dr. Vimi Varghese, Consultant Transplant Pulmonologist, and Dr. Hari Kishan Gonuguntla, Consultant Interventional Pulmonologist.